Business

We’re proud to share that Deciphex and Diagnexia have been recognised at the Pharma Industry Awards UK 2025! 🏆 Best Use of Technology Award – Diagnexia & East Sussex Healthcare NHS Trust 🏆 Partnership Alliance of the Year –...

Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI's datasets from 7 million slides, perhaps most of...

From the Proscia blog: For HNL Lab Medicine, digital pathology isn’t just a technology upgrade—it’s a strategic business decision that has already delivered measurable gains. By partnering with Proscia, HNL Lab Medicine has not only...

Cancer patients will benefit from the potential for faster diagnosis and better access to specialist opinions, following the go-live of a digital pathology solution across five NHS sites in Devon and Cornwall.  Technical and...

Tempus: Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a...

Lumea, the U.S. leader in primary clinical digital pathology, is proud to announce it has received four prestigious awards this fall, recognizing the company's rapid growth and transformative impact on cancer diagnostics. Lumea was named to the...